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Introduction
As the maternal age increases to middle age, the fre-
quency of chromosomal anomalies increases; thus, pre-
natal diagnostic methods are used more often in order
to diagnose such cases effectively.
When identifying cases at risk of having a baby with
chromosomal anomaly and suggesting the use of inva-
sive prenatal diagnosis methods, besides an advanced
maternal age and a previous history of fetal chromo-
somal anomaly, abnormal ultrasonography (USG) re-
sults and results from the triple test and first-trimester
screening test (nuchal translucency, human chorionic
gonadotropin, pregnancy-associated plasma protein-A)
can be effective in the determination [1,2].
In order to have a definite diagnosis of pregnancies
having a risk of fetal chromosomal anomaly, prenatal
diagnosis methods, such as chorionic villus sampling and
early amniocentesis in the first trimester and amnio-
centesis or cordocentesis in the second trimester, can be
applied. Among the methods mentioned above, amnio-
centesis is still the most used invasive prenatal diagno-
sis method, because (1) chorionic villus sampling requires
more experience, and the fetal loss and complication
rates are high; (2) there are no controlled studies on
the safety of early amniocentesis, and current reports
present a high rate of fetal loss and some deformities 
in some fetuses; and (3) cordocentesis requires more
experience and fetal loss rate is high [2,3]. However,
when quick results are required, cordocentesis can 
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SUMMARY
Objective: To evaluate the results of cordocentesis carried out in our clinic at Meram Medicine Faculty of 
Selcuk University in Konya, Turkey.
Materials and Methods: Cytogenetic results and complication data were obtained by cordocentesis from 
250 pregnancies performed in our clinic.
Results: Adequate amount of cord blood was taken 98% of the time, the successful culture rate was 92.8%, 
and none of the 18 cases in which no proliferation was detected in the culture accepted a new intervention.
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out for various indications. According to cytogenetic evaluation, chromosomal abnormality was detected in 
12 cases (5.17%), including four cases of trisomy 21, four cases of trisomy 18, one case of trisomy 13, one case
of triploidy (69,XXX) and two cases of chromosomal inversion. Of the 250 cordocentesis cases, there were 
12 (4.8%) cases of fetal loss, including four cases of rupture of membranes, four cases of abdominal pain and
vaginal bleeding and four cases of a spontaneous abortus. In 53 (21.2%) cases, cordocentesis was performed
because of hydrops fetalis; and of the total 12 losses, six were in this group. The fetal loss rate was 11.32% in the
hydrops fetalis group.
Conclusion: If cordocentesis is carried out by highly skilled physicians and optimal culture conditions are avail-
able, cordocentesis is an invasive prenatal diagnostic and therapeutic procedure that is performed secondary to
amniocentesis with high accuracy and safety. In cases of hydrops fetalis in which cordocentesis is carried out,
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be performed, since it is highly safe with reasonable
complication frequency.
Materials and Methods
This study consisted of 250 cases in which cordocente-
sis was carried out in the Department of Obstetrics
and Gynecology at Meram Medicine Faculty of Selcuk
University in Konya, Turkey from June 2001 to June 2006.
Cordocentesis was performed for various indications.
A second cordocentesis was offered to 18 patients,
because amniotic cells could not be cultured. None of
these patients accepted a second intervention.
In this study, the cytogenetic results and complica-
tion data of the cordocentesis procedure performed
on 250 pregnant women were examined and analyzed.
These women were admitted to our clinic because of
advanced maternal age, a history of amniocentesis due
to high risk of carrying a chromosomally abnormal
fetus in whom no karyotype result could be obtained
by amniocentesis, and a previous history of having 
a chromosomally abnormal fetus.
Prior to cordocentesis, a detailed interview with the
family was conducted. A detailed history was obtained
after determining the career position, educational back-
ground and economical status. The complications and
risks of cordocentesis were explained to the family in
detail. The risk of abortion (1–3%) due to the procedure
was explained to the families, and the signatures of the
couples for their informed consent were obtained.
Cordocentesis was performed between the 17th
and 28th gestational weeks in 250 cases that accepted
the procedure. All cordocentesis procedures were car-
ried out by the same perinatologist. Before the attempt,
each fetus was examined in detail using USG and the
anomaly type detected was recorded. The localization
of the placenta, amniotic fluid quantity, needle inser-
tion site, the distance of the fetus to the needle in-
sertion site, and fetal position were assessed. Before
starting the procedure of cordocentesis, essential prep-
arations were made. After preparing the abdominal
region with povidone-iodine, cordocentesis was per-
formed, which was accompanied by USG using a 
sterile spinal needle with the freehand technique trans-
abdominally. For cytogenetic analysis, 0.5–1 mL fetal
blood was taken using a heparinized syringe. Anti-Rh
IgG (300 µg) was administered to cases at risk of Rh
alloimmunization.
The blood obtained from cordocentesis was sent
to the Meram Medicine Faculty Genetic Laboratory of
Selcuk University. Following laboratory processing and
by using standard methods, chromosomal preparations
were prepared from the cells taken from cell cultures.
Quantitative and structural chromosome disorders
observed in the cases were examined and assessed in
accordance with the International System for Human
Cytogenetic Nomenclature (ISCN, 1995). The patients
who had normal results were called for routine prena-
tal visits until delivery. Pregnancies with chromosomal
anomalies incompatible with life and with multiple
anomalies detected on USG were terminated at the
request of the family.
For statistical evaluation of the results, SPSS 10.0
for Windows was used. Data are expressed as mean ±
standard deviation. Chi-squared test was used to com-
pare the data obtained. Statistical significance was
accepted at p < 0.05.
Results
The average maternal age was 27.85 ± 6.66 years (range,
17–43 years). Thirty-five (14%) patients were ≥ 35 years
of age, 18 (7.2%) were below the age of 20, and 197
(78.8%) were between 20 and 35 years. Eighty-eight
(35.2%) were nulliparous, and 162 (64.8%) were mul-
tiparous. While eight (3.2%) of the cases had chronic
disorder, only two had a genetic disorder (beta-tha-
lassemia minor). There was consanguinity between the
women and their husbands in 64 cases (25.6%).
Eight (3.2%) patients had a history of giving birth
to an infant with anomaly. No relationship between the
history of an infant with anomaly and chromosomal
abnormality could be established.
Cordocentesis was performed in 124 (49.6%) pa-
tients before or during the 24th week of pregnancy and
in 126 (50.4%) patients between the 24th and 28th week
of pregnancy.
Most of the cases that underwent the cordocente-
sis procedure comprised patients who showed signs 
of fetal anomalies on USG and patients who were
referred to our clinic with suspicion of chromosomal
abnormality because of fetal anomaly detected on USG.
The major indication for cordocentesis was abnormal
USG results, which accounted for 194 (77.6%) cases.
In the cases for which cordocentesis was performed,
14 (5.6%) had failed cell culture in amniocentesis, 15
(6%) had advanced maternal age, 15 (5%) had a poor
obstetric history (e.g. having an infant with anomaly),
10 (4%) had high risk of chromosomal abnormality on
triple test, and two (0.8%) had mosaicism on amnio-
centesis.
Table 1 shows the fetal anomalies and their fre-
quencies in 194 cases that underwent cordocentesis,
based on anomaly assessed on USG.
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According to the USG results, hydrops fetalis was
the most frequent anomaly in 53 (27.31%) cases. Next,
41 (21.13%) cases had multiple fetal anomalies and
34 (17.52%) had central nervous system anomalies.
Among the central nervous system anomalies, the
most frequent pathology was hydrocephaly. In addi-
tion to this group of anomalies, microcephaly, choroid
plexus cysts and meningomyelocele were among the
other frequent anomalies. In the cases with multiple
fetal anomalies, two or more anomalies existed together
on USG.
A second attempt at puncture was required in only
18 cases, so the failure rate at first puncture was 7.2%;
only two attempts could be made in each examination.
Fetal blood samples taken from five out of 250
cases were found to be insufficient by the laboratory.
Thus, the rate of obtaining sufficient cord blood was
98%. In 18 (7.2%) of the 250 fetal blood samples,
there was a failed cell culture; thus, the successful cord
blood culture rate was 92.8%. Insufficient fetal blood
in the five (2%) samples and contamination in the 
13 (5.2%) samples were deemed to be the cause of cul-
ture failure. None of the 18 cases with a failed culture
accepted a second intervention.
Out of the 232 cases with successful cell culture,
220 (94.82%) revealed normal results of chromosomal
analysis and 12 (4.8%) had a chromosomal anomaly.
The chromosomal anomalies were: trisomy 18 (four
cases), trisomy 21 (four cases), trisomy 13 (one case),
inversion (two cases), and triploidy (69,XXX; one case)
(Table 2).
Of the cases with chromosomal anomalies, eight
patients were aged 35 years or younger, and four
patients were over 35 years of age. Seven patients were
multiparous and five were primiparous. In nine of the
patients, the procedure was conducted in the 24th week
of pregnancy and later. The procedure was performed,
because eight patients had abnormal USG results, three
were of advanced maternal age, and one was of ad-
vanced maternal age and had abnormal USG results.
Ten of the pregnancies with quantitative chromo-
somal anomaly were terminated according to the re-
quest of the family. Two cases in which structural
chromosomal abnormality was detected had a delivery
in our clinic on time, and no abnormality was detected
in the babies.
The results obtained from the patients who under-
went cordocentesis are shown in Table 3.
Of the 250 patients who underwent cordocentesis,
12 (4.8%) had fetal loss due to the procedure, includ-
ing four with rupture of the membranes, four with
abdominal cramps and vaginal bleeding, and four 
in which spontaneous abortion was detected. In 53
(21.2%) of the cases, cordocentesis was performed
because of hydrops fetalis, and six of the total fetal
losses occurred in this group. Thus, the fetal loss rate
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Table 1. Abnormal ultrasonographic findings in 194 
cordocentesis cases
Ultrasonographic findings n (%)
Hydrops fetalis 53 (27.31)
Multiple fetal anomalies 41 (21.13)
Central nervous system anomalies 34 (17.52)
Oligohydramnios 23 (11.85)
Intrauterine retardation 15 (7.73)
Polyhydramnios 13 (6.70)
Renal anomaly 5 (2.57)
Omphalocele 5 (2.57)
Extremity anomaly 5 (2.57)
Table 2. Chromosomal anomalies in 12 cordocentesis (CS) cases
Maternal age (yr) Gestational weeks at CS Indications for CS Karyotype
21 26 Anomaly on USG 47,XY,+21
23 18 Anomaly on USG 47,XX,+18
23 25 Anomaly on USG 47,XY,+18
24 25 Anomaly on USG 69,XXX
25 19 Anomaly on USG 47,XY,+13
26 25 Anomaly on USG 47,XY,+18
27 26 Anomaly on USG 46,XX inv(9)
32 23 Anomaly on USG 47,XX,+21
36 24 Anomaly on USG + 47,XX,+18
late maternal age
39 22 Late maternal age 47,XY,+21
39 27 Late maternal age 46,XY inv(9qh)
40 20 Late maternal age 47,XX,+21
USG = ultrasonography; inv = inversion.
was 11.32% in this group. In the non-hydrops fetalis
group, the fetal loss rate was 3.04%. The fetuses lost in
the non-hydrops fetalis group all had normal USG
findings.
Discussion
Cordocentesis seems to be a widely accepted method
for prenatal diagnosis. The rate of complications due
to the procedure is one of the most crucial factor as to
whether or not the patients accept this method of di-
agnosis, and the most important complication is fetal
loss. Today, there seems to be a major transformation
regarding the management and timing of cordocente-
sis, and procedures performed during midgestation are
now performed earlier.
Because there is no alternative method that can be
used for the patient population concerned, controlled
studies cannot be conducted; and because of a lack of
a proper controlled group, only cohort studies can be
performed. The procedure can only be applied, owing
to ethical reasons, to patient population with abnor-
mal fetus. Therefore, it seems difficult to determine
that fetal loss was associated purely to the procedure,
as these fetuses were already at high risk for intra-
uterine death. Results of studies conducted previously
reflected that the fetal loss rates were due to both 
procedure and underlying fetal pathologies.
Studies conducted have shown that the determi-
nants of fetal loss rate are: age at cordocentesis, expe-
rience of the operator, indication for cordocentesis,
and cordocentesis site.
A comprehensive and safe study that examined real
fetal loss due to the procedure was conducted by
Ghidini et al [4]. Ghidini et al grouped the patients
who underwent cordocentesis into those having high
or low risk. The low-risk group did not include the
patients with chromosomal anomaly, intrauterine re-
tardation, fetal infection or nonimmune hydrops fetalis.
In this group, the fetal loss rate was 3% using the free-
hand technique. In another study [5], the group of
1,020 women who had cordocentesis and the con-
trolled group of 1,020 women who did not have cor-
docentesis were compared, and it was shown that
fetal loss was associated with midgestational cordo-
centesis. When compared with the 1.8% basal fetal
loss rate observed during midgestational period in the
controlled group patients, an increased fetal loss rate
of about 3.2% were found in the patients who under-
went midgestational cordocentesis. It was reported
that the calculated rate of 1.4% is the real fetal loss
rate due to cordocentesis [5]. In the other studies, the
rates of fetal loss due to the procedure varied from
1.9% to 3.1% [6,7]. This rate increases with pregnan-
cies having high risks, such as those with nonimmune
hydrops fetalis.
In our study, fetal loss due to the procedure was
found in 12 (4.8%) out of a total of 250 cases of cor-
docentesis. In this study, the possible reasons for the
high fetal loss rate were, for the majority in the study
population, the fetal anomalies detected on USG for
the high-risk pregnancies and the high likelihood of
having a high-risk pregnancy. Fifty-three (21.2%) of our
cases had cordocentesis because of hydrops fetalis,
and six of the total fetal losses occurred in this group.
The fetal loss rate was 11.32% in this group and 3.04%
in the other group.
The rate of obtaining sufficient cord blood in our
study was 98%, and the successful culture rate with
cord blood was 92.8%. These results are consistent
with those of previous studies [8]. None of the 18
patients with a failed cell culture accepted a second
intervention.
According to the results of our cytogenetic exami-
nation, 12 (5.17%) cases had chromosomal anomalies.
Although this rate was significantly lower than the rates
reported in many studies [9], a similar rate of chromo-
somal anomaly was reported by Kabra et al [10]. Our
results revealed that four had trisomy 18, four had 
trisomy 21, one had trisomy 13, one had triploidy
(69,XXX), and two had chromosomal inversion. In our
study, numerical chromosomal anomalies were found
more often, as in the study by den Hollander et al [11].
The rate of patients with chromosomal anomalies found
with multiple fetal anomalies on USG was high. Of the
12 fetuses with chromosomal anomalies, we detected
multiple fetal anomalies on USG in eight of them.
During the procedure, almost every case had bleed-
ing at the site of fetal blood sampling. However, the
bleeding was not severe enough to cause hematoma
formation or affect the fetal loss rate. Moreover, fetal
bradycardia due to the procedure was found to be 
of high incidence. However, it was not high enough to
warrant an intervention or cause fetal loss. None of
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Table 3. Findings from the cordocentesis cases (n = 250)
Findings n (%)
Sufficient cord blood 245 (98.00)
Insufficient cord blood 5 (2.00)
Successful cell culture 232 (92.80)
Cell culture failure 18 (7.20)
Normal chromosomal result 220 (94.82)
Chromosomal anomaly 12 (5.17)
Abortus 12 (4.80)
the patients developed chorioamnionitis. The results
obtained in our study are consistent with those reported
by Tongsong et al [12].
In conclusion, our results show that cordocentesis
is safe and effective if conducted by experienced physi-
cians under proper laboratory conditions. In addition,
cordocentesis is an important invasive prenatal diag-
nosis and treatment method but is secondary to amnio-
centesis since there are less complications associated
with amniocentesis. The fact that the results of cordo-
centesis can be obtained earlier than those of amnio-
centesis can be regarded as an advantage, particularly
for patients who are after the 20th week of pregnancy.
It should also be noted that with cases in which cor-
docentesis is performed, the risk of fetal loss may be
greater because of multiple fetal anomalies, chiefly
hydrops fetalis.
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